World Feb 16, 2021
WHO approval of AstraZeneca-Oxford vaccine widens access in developing world
The WHO's review found that the vaccine met the "must-have" criteria for safety and that its efficacy benefits outweighed its risks.
World / Science & Health Feb 7, 2021
Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says
British drugmaker AstraZeneca said on Saturday its vaccine developed with Oxford University appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial. The study from South Africa's University of the Witwatersrand ...
World / Science & Health Feb 4, 2021
AstraZeneca and Pfizer vaccines to be combined in Oxford trial
The trial will allow researchers to see whether two shots of different vaccines produce better or worse results than two doses of the same product.
Asia Pacific Jan 23, 2021
Inside India's Serum Institute, the world's biggest vaccine factory
The firm is producing millions of doses of the Covishield vaccine, developed by AstraZeneca and Oxford University, for India and much of the developing world.
World / Science & Health Dec 30, 2020
Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval
by Suzi Ring
AstraZeneca PLC and the University of Oxford’s Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations.
World / Science & Health | FOCUS Dec 27, 2020
How a British COVID-19 vaccine went from pole position to troubled start
by Steve Stecklow, Andrew Macaskill, Ludwig Burger, Kate Kelland and Emilio Parodi
A review of records and interviews with scientists and industry figures gives a detailed account of what went wrong with the Oxford-AstraZeneca study.
World / Science & Health Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
by Kate Kelland
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
World / Science & Health Dec 4, 2020
Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccine
by Ludwig Burger, Kate Kelland and Abhirup Roy
The two partners have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine.
World / Science & Health Nov 27, 2020
AstraZeneca considers extra global vaccine trial as questions mount
Many low- and middle-income countries are relying on the firm, which has pledged to sell its vaccine at cost during the pandemic.
World / Science & Health | FOCUS Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
by Alistair Smout, Kate Kelland and Ludwig Burger
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
World / Science & Health Nov 21, 2020
Virus infection creates immunity for at least six months, Oxford study finds
Individuals infected with coronavirus are unlikely to catch the illness again for at least six months, researchers at the University of Oxford said Friday. The finding comes as part of a large-scale study into COVID-19 reinfection after observations from healthcare professionals that the phenomenon was ...
World / Science & Health Nov 4, 2020
Oxford COVID-19 vaccine trial results due this year but not there yet, trial chief says
A vaccine that works is seen as a game-changer in the battle against the coronavirus, which has killed more than 1.2 million people worldwide.